Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

Полное описание

Библиографические подробности
Главные авторы:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
Формат:	Статья
Язык:	English
Опубликовано:	Taylor & Francis Group 2017-04-01
Серии:	Expert Review of Vaccines
Предметы:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
Online-ссылка:	http://dx.doi.org/10.1080/14760584.2017.1294068

Схожие документы

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
по: Piyada Angsuwatcharakon, и др.
Опубликовано: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
по: Jia Li, и др.
Опубликовано: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
по: D.J. Briggs, и др.

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
по: Jing Wang, и др.
Опубликовано: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
по: A. L. Kravtsov, и др.
Опубликовано: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
по: Hua-Kun Lv, и др.
Опубликовано: (2025-02-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
по: Lidong Wang, и др.
Опубликовано: (2024-03-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
по: Scott Preiss, и др.
Опубликовано: (2018-06-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
по: Nianmin Shi, и др.
Опубликовано: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
по: Zheng-Gang Zhu, и др.
Опубликовано: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
по: Jia Li, и др.
Опубликовано: (2024-12-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
по: Gagandeep Kang, и др.
Опубликовано: (2023-07-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
по: Pornthep Chanthavanich, и др.
Опубликовано: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
по: Xiaohong Wu, и др.
Опубликовано: (2023-08-01)

Infection and Prevention of Rabies Viruses
по: Shiu-Jau Chen, и др.
Опубликовано: (2025-02-01)

Development of mRNA rabies vaccines
по: Zixin Fang, и др.
Опубликовано: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
по: Thomas Moulenat, и др.
Опубликовано: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
по: Zhenzhen Liang, и др.
Опубликовано: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
по: Lei Zhang, и др.
Опубликовано: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
по: S. V. Generalov, и др.
Опубликовано: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
по: Xingyu Zhou, и др.
Опубликовано: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
по: Heng Shen, и др.
Опубликовано: (2021-02-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
по: E. G. Abramova, и др.
Опубликовано: (2019-11-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
по: Pooneh Rahimi, и др.
Опубликовано: (2014-08-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
по: Xiaoyuan Huang, и др.
Опубликовано: (2023-01-01)

Retrospective study of rabies epidemiology in Ukraine (1950-2019)
по: I. F. Makovska, и др.
Опубликовано: (2020-03-01)

Management of rabies
по: J. Weyer, и др.
Опубликовано: (2019-07-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
по: Irina Matveeva, и др.
Опубликовано: (2022-09-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
по: Emily G Pieracci, и др.
Опубликовано: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
по: Sunil Karande, и др.
Опубликовано: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
по: SILVA Jorgete M., и др.
Опубликовано: (1997-01-01)

A case of human survival of rabies, South Africa
по: Jacqueline Weyer, и др.
Опубликовано: (2016-07-01)

Factors related to vaccines for both patients exposed with rabies and dogs
по: Lam Quy Ngo, и др.
Опубликовано: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
по: Lam Quy Ngo, и др.
Опубликовано: (2022-03-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
по: Jun Luo, и др.
Опубликовано: (2020-04-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
по: Mahdika Ambarwaty, и др.
Опубликовано: (2023-12-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
по: Gadey Sampath, и др.
Опубликовано: (2017-07-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
по: Anurag Agarwal, и др.
Опубликовано: (2022-11-01)

The Role of the Gray Wolf in Rabies Transmission in Iran and Preliminary Assessment of an Oral Rabies Vaccine in this Animal
по: Alireza Gholami, и др.
Опубликовано: (2017-07-01)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
по: Weerawan Hattasingh, и др.
Опубликовано: (2022-01-01)